REV7可以抵消DNA双链断裂切除,并影响PARP抑制
Guotai Xu1, J Ross Chapman2, Inger Brandsma3
1Division of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
Nature
|March 25, 2015
概括
REV7的损失恢复了BRCA1缺乏细胞中的同源重组 (HR) DNA修复,导致PARP抑制剂耐药性. 这种REV7功能是53BP1的下游,并影响DNA修复路径的选择.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 癌症研究 癌症研究
背景情况:
- 同源重组 (HR) 对于无错误的DNA双链断裂 (DSB) 修复至关重要.
- 在某些癌症中,BRCA1缺乏导致PARP抑制剂的合成致死性.
- 药物耐药性可能来自HR恢复,但BRCA1-独立HR恢复的机制尚不清楚.
研究的目的:
- 研究BRCA1独立HR恢复的机制.
- 确定参与BRCA1缺陷细胞中DNA修复途径选择的新型因素.
- 了解REV7在DNA修复和PARP抑制剂耐药性的作用.
主要方法:
- 使用了老鼠和人类细胞系.
- 研究了DNA修复途径,包括HR和非同类末端结合 (NHEJ).
- 分析了使用染色质通路对DSB的蛋白质招募.
- 研究了ATM激酶抑制的作用.
主要成果:
- 在BRCA1缺乏细胞中,REV7 (MAD2L2) 的损失重新建立了CTIP依赖的末端切除.
- REV7损失恢复HR,从而赋予PARP抑制剂的耐药性.
- 在DSB中REV7的招募取决于H2AX-MDC1-RNF8-RNF168-53BP1通路.
- 在免疫球蛋白类切换重组过程中,REV7阻断了DSB切除,以促进NHEJ.
- 通过ATM激酶抑制,可以逆转REV7介导的抗性.
结论:
- 在BRCA1缺乏细胞中,REV7在阻断HR和促进NHEJ方面发挥着关键作用.
- 在协调DSB修复路径选择方面,REV7在53BP1的下游作用.
- 针对REV7可能提供克服PARP抑制剂耐药性的策略.
相关概念视频
Restarting Stalled Replication Forks
6.6K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.6K
DNA Damage can Stall the Cell Cycle
10.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle
3.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Long-patch Base Excision Repair
8.3K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
8.3K
Homologous Recombination
65.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.9K
Base Excision Repair
28.5K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
28.5K


